Evaluation of the Effectiveness, Safety, and Tolerability of LevoCept (Levonorgestrel-Releasing Intrauterine System) for Long-Acting Reversible Contraception
A study for healthy, sexually active women using a hormone-releasing intrauterine contraceptive called LevoCept
Sponsor: ContraMed
Enrolling: Female Patients Only
Clinic Visits: 6
IRB Number: AAAR0663
U.S. Govt. ID: NCT02882191
Contact: Claudia Roca: 646-317-4754 / cr479@columbia.edu
Additional Study Information: This is a study looking to evaluate how well a new hormone-releasing Intrauterine Contraceptive called LevoCept works in healthy, sexually active women. The study will consist of 6 study visits including a screening visit prior to enrollment and monthly telephone calls over the course of a year. The study visits will vary but mostly consist of physical and gynecological exams, urine pregnancy tests, and vaginal ultrasounds. Women who volunteer will also be given an electronic diary to keep daily along with instructions. The first visit will take about an hour. If you are eligible and you decide to participate, the other visits will take from 30 minutes to an hour. You will be compensated for your time and travel upon completion of each study visit ($50 compensation per visit).
This study is closed
Investigator
Carolyn Westhoff, MD
Do You Qualify?
Are you sexually active? Yes No
Are you willing to use an intrauterine contraceptive as your primary method of contraception while in the study? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Claudia Roca
cr479@columbia.edu
646-317-4754